About Randall Hyer
Randall Hyer is a chief executive officer and director at Merlin Biotech.
Experience
This experience comes from Randall Hyer's profile and from SEC filings. For roles taken from filings, the years are when the filings name Randall Hyer in the role, so the role may have started earlier or lasted longer.
PC
Pennsylvania Biotechnology Center Current
Chairman, Innovation and Translational Medicine
2024 – Present
Merlin Biotech, Inc. Current
Chief Executive Officer and director
2022 – Present · Doylestown, PA
Develops potential cancer treatments for adults and children using messenger RNA.
BI
BARUCH S. BLUMBERG INSTITUTE Current
Distinguished Professor of Translational Medicine
2021 – Present
CL
CrisisCommunication.net, LLC Current
Co-founder and Principal
2011 – Present
CC
Center For Risk Communication Current
Deputy Director
2005 – Present
MO
Moderna
Senior Consultant
2020 – 2022
DT
Dynavax Technologies
Vice President Clinical Development and Medical Affairs, Head Drug Safety and Phamacovigilance
2015 – 2020
SA
Sandoz
Head, Global Medical Affairs
2012 – 2014
MJ
MSD (KK) Japan
Senior Advisor, Vaccines
2009 – 2011
MD
Merck Vaccine Division
Senior Medical Director
2005 – 2009
WO
World Health Organization
Medical Officer, Alert and Response Operations and Civil-Military Liaison Officer
2001 – 2005
UN
US Navy
Medical Epidemiologist
1994 – 2001
US
United States Senate
Congressional Fellow
1996
Key Colleagues at Startups
The people Randall Hyer works with at each company, as listed on that company's latest Form D.
Merlin Biotech, Inc. · Form D, Aug 11, 2026
JB
Jay Bhatia
Director
NH
Nikhil Heble
Executive officer
Nick Spring
Business Strategy & Commercialization
Carol Brosgart
Director
Loren Danzis
Partner, Fox Rothschild LLP and director